Measles Outbreak in a French Roma Community in the Provence-Alpes-Côte dAzur region France May to July 2017.

Wednesday, 19th of September 2018 Print

Int J Infect Dis. 2018 Sep 7. pii: S1201-9712(18)34512-0. doi: 10.1016/j.ijid.2018.08.023. [Epub ahead of print]

Measles Outbreak in a French Roma Community in the Provence-Alpes-Côte dAzur region France May to July 2017.

Godefroy R1 Chaud P2 Ninove L3 Julia D4 Decoppet A5 Casha P6 Hraiech S1 Brouqui P7 Cassir N8.

Author information

Abstract

OBJECTIVES:

To analyse a measles outbreak in a Roma community.

METHODS:

We describe a community-wide outbreak of genotype D8 measles that took place in southeastern France between May and July 2017 along with the control measures adopted.

RESULTS:

We identified a total of eighteen cases between six months and 24 years old. All cases were unvaccinated or incompletely vaccinated and belonged to a sedentary French Roma community. Most of them (67%) were hospitalised with three cases (17%) of severe measles including one death of a 16-year-old girl who had previously received oral corticosteroids. The later was the only lethal case notified in France during the year 2017. Control measures included intensification of surveillance isolation of cases and a large vaccination campaign in this Roma community. During the outbreak period there was no case of healthcare-associated measles transmission. A broad adherence to vaccination through the mediating role of both the chief of the community and the pastor allowed reaching completed vaccination coverage of 90%.

CONCLUSIONS:

Efforts should be concentrated to enhance access to health services for minorities such as the Roma community characterized by low vaccination coverage. Trustful relationship with leaders of the community is essential to ensure adherence to vaccination. In France attributable mortality to measles is low and concerns mainly unvaccinated and immuodepressed patients.

Copyright © 2018. Published by Elsevier Ltd.

KEYWORDS:

Roma community; measles; outbreak; vaccines

PMID: 30201504 DOI: 10.1016/j.ijid.2018.08.023

 

Special Postings

;

Highly Accessed

Website Views

2041933